Previous 10 | Next 10 |
home / stock / medif / medif news
BARRIE, Ontario, March 26, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivat...
MediPharm Labs (MEDIF) announces that it has entered into a supply agreement with the Société Quebecois Du Cannabis, in a bid to tap the Quebec market by introducing a variety of cannabis concentrate based products in the region.MediPharm cannabis products will be for sale...
Quebec marks the Company’s 7 th provincial distribution supply agreement MediPharm Labs expanded distribution footprint represents potential coverage of an estimated 95%+ of retail market in Canada MediPharm Labs will be selling its MediPharm Labs and ...
MediPharm Labs (MEDIF) announce its wholly owned subsidiary, MediPharm Labs Australia, has entered into a new GMP white-label supply and contract manufacturing agreement with Cannim Australia.The company has also commenced registrations for the launch of next generations over-the-counter...
TORONTO, March 08, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”), a global leader in specialized, research-driven cannabis extraction, distillation and derivative products, is pleased to an...
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, March 05, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a gl...
MediPharm Labs (MEDIF) has agreed to increase the size of its previously announced "bought deal" offering of 50M units of the company at a price of $0.58/unit for gross proceeds of $29M.Each unit will be comprised of one share and one share purchase warrant, with each warrant exercisable to a...
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, March 02, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a gl...
MediPharm Labs (MEDIF) announce that it has entered into an agreement with Cantor Fitzgerald Canada, as lead underwriter and sole bookrunner on behalf of a syndicate of underwriters, to purchase, on a bought deal basis, 34.5M units at a price of $0.58/unit for gross proceeds of $20M.Each unit...
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, March 01, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a gl...
News, Short Squeeze, Breakout and More Instantly...
MediPharm Labs Announces Voting Results From the 2024 Annual Meeting of Shareholders Canada NewsWire TORONTO , June 26, 2024 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical comp...
MediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose Aerosols Canada NewsWire MediPharm has licenced global manufacturing, distribution, and sales rights of the novel advanced medical cannabis technology from Remidose Aerosols. Product...